Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis

T Bellnier, GW Brown, TR Ortega - Mental Health Clinician, 2018 - meridian.allenpress.com
Introduction: Medical cannabis (MC) is commonly claimed to be an effective treatment for
chronic or refractory pain. With interest in MC in the United States growing, as evidenced by …

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain

TL Burns, JR Ineck - Annals of Pharmacotherapy, 2006 - journals.sagepub.com
Objective: To review the literature concerning the physiology of the endocannabinoid
system, current drug development of cannabinoid agonists, and current clinical research on …

[HTML][HTML] Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside

EJ Rahn, AG Hohmann - Neurotherapeutics, 2009 - Elsevier
Neuropathic pain is a debilitating form of chronic pain resulting from nerve injury, disease
states, or toxic insults. Neuropathic pain is often refractory to conventional …

[HTML][HTML] Cannabinoids in pain management and palliative medicine: An overview of systematic reviews and prospective observational studies

W Häuser, MA Fitzcharles, L Radbruch… - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background There are conflicting interpretations of the evidence regarding the efficacy,
tolerability, and safety of cannabinoids in pain management and palliative medicine …

Efficacy and adverse effects of medical marijuana for chronic noncancer pain: systematic review of randomized controlled trials

A Deshpande, A Mailis-Gagnon, N Zoheiry… - Canadian Family …, 2015 - cfp.ca
Objective To determine if medical marijuana provides pain relief for patients with chronic
noncancer pain (CNCP) and to determine the therapeutic dose, adverse effects, and specific …

[HTML][HTML] Cannabis in pain treatment: clinical and research considerations

SR Savage, A Romero-Sandoval, M Schatman… - The Journal of …, 2016 - Elsevier
Cannabinoids show promise as therapeutic agents, particularly as analgesics, but their
development and clinical use has been complicated by recognition of their botanical source …

[HTML][HTML] Medical cannabis for chronic nonmalignant pain management

M Hameed, S Prasad, E Jain, BN Dogrul… - Current Pain and …, 2023 - Springer
Abstract Purpose of Review Cannabis has been used since ancient times for medical and
recreational research. This review article will document the validity of how medical cannabis …

Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms

GM Allan, CR Finley, J Ton, D Perry, J Ramji… - Canadian Family …, 2018 - cfp.ca
Objective To determine the effects of medical cannabinoids on pain, spasticity, and nausea
and vomiting, and to identify adverse events. Data sources MEDLINE, the Cochrane …

Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of …

N Krcevski‐Skvarc, C Wells… - European Journal of …, 2018 - Wiley Online Library
Background There is considerable public and political interest in the use of cannabis
products for medical purposes. Methods The task force of the European Pain Federation …

[HTML][HTML] Dronabinol is a safe long-term treatment option for neuropathic pain patients

S Schimrigk, M Marziniak, C Neubauer, EM Kugler… - European …, 2017 - karger.com
Abstract Treatment of neuropathic pain (NP) symptoms associated with multiple sclerosis
(MS) is frequently insufficient. Yet, cannabis is still rarely offered for treatment of pain. This …